[Tai Duan] Filed pursuant to Taiwan Stock Exchange Corporation letter No. 1121801204, code Tai-Zheng-Shang-Yi
Published ・ Source Taiwan | 臺灣證券交易所
台端興業 announced that investment balances in four funds and redemption proceeds remain outstanding. Their fair value was assessed at 0, signaling significant financial risk and an impact on shareholders’ equity.
Companies mentioned:Ayers Alliance Financial Group Ltd.、STI PF Limited、City Credit Investment Bank Limited、CCAM Co., Ltd.
【PharmaEssentia】New drug BESREMi (Ropeginterferon alfa-2b-njft) approved by the U.S. FDA to treat adults with essential thrombocythemia (ET)
Published ・ Source Taiwan | 臺灣證券交易所
PharmaEssentia’s new drug BESREMi has received U.S. FDA approval to treat adults with essential thrombocythemia. The expanded indication is expected to help develop the U.S. market, and the company has launched related sales and marketing plans.
【臻鼎-KY】Subsidiary PENG SHEN TECHNOLOGY (THAILAND) CO., LTD. announces acquisition of machinery and equipment
Published ・ Source Taiwan | 臺灣證券交易所
A subsidiary of Zhen Ding-KY acquired equipment in Thailand for about 1.078 billion New Taiwan dollars for business operations. The price was determined through competitive bidding and negotiations based on market rates.